Dr. Soucier studies various aspects of heart diseases, particularly heart failure and hypertrophic cardiomyopathy (HCM), which is a condition where the heart muscle becomes abnormally thick. He examines how factors like socioeconomic status affect patient outcomes, the effectiveness of medications used in treating heart conditions, and ways to encourage patients to be more active to prevent hospital readmissions. His research also includes the use of specific treatments, such as loop diuretics and spironolactone, to help manage heart failure symptoms.
Key findings
In one study, patients with heart failure using the natriuretic response prediction equation had an increase in daily urine output by nearly 1.2 liters and improved fluid loss.
Analysis of 953 patients with HCM showed that those from lower socioeconomic backgrounds were ten times more likely to die without specialized care, but this risk was removed when they received it.
In another research, patients participating in a specialized heart failure clinic increased their usage of heart medications from an average of 0.54 to 1.52 at target doses, improving their heart function from 21.8% to 36.2%.
A study found that among 50 heart failure patients, 26% were readmitted to the hospital within 30 days, and those who were less active were five times more likely to be readmitted.
Research on the effects of spironolactone indicated that blood vessel function improved significantly after 4 weeks of treatment, showing continued benefits at 8 weeks.
Frequently asked questions
Does Dr. Soucier study heart failure?
Yes, Dr. Soucier specializes in heart failure and works on developing better treatment strategies for patients with this condition.
What conditions does Dr. Soucier focus on?
Dr. Soucier focuses on heart failure and hypertrophic cardiomyopathy, exploring how various treatments and patient factors impact outcomes.
How can Dr. Soucier's research help patients?
His research helps patients by identifying effective treatments and emphasizing the importance of specialized care and physical activity to improve their health outcomes.
Has Dr. Soucier studied the impact of socioeconomic status on heart disease?
Yes, he has researched how socioeconomic status affects health outcomes in patients with hypertrophic cardiomyopathy.
What treatments has Dr. Soucier investigated?
He has studied various treatments including loop diuretics, spironolactone, and specific management strategies for post-surgical atrial fibrillation.
Publications in plain English
Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
2021
Journal of the American College of Cardiology
Rao VS, Ivey-Miranda JB, Cox ZL, Riello R, Griffin M +15 more
Plain English Researchers studied a method to better predict how patients with heart failure respond to loop diuretics, which are medications used to help remove excess fluid. They validated a prediction equation called the natriuretic response prediction equation (NRPE) and found it effectively predicted urine sodium output levels, showing a strong accuracy (with scores over 0.90). Using this method helped increase daily urine output by nearly 1.2 liters and improved fluid loss and weight management significantly.
Who this helps: This benefits patients with heart failure who struggle with fluid retention.
Access and Outcomes Among Hypertrophic Cardiomyopathy Patients in a Large Integrated Health System.
2020
Journal of the American Heart Association
Thomas A, Papoutsidakis N, Spatz E, Testani J, Soucier R +9 more
Plain English The study looked at patients with hypertrophic cardiomyopathy (HCM), a common heart condition, to see how their socioeconomic status affected their health outcomes within a large healthcare system. Researchers found that of the 953 patients studied, those from lower socioeconomic backgrounds who received general cardiology care were ten times more likely to die compared to those from higher socioeconomic backgrounds. However, when lower socioeconomic patients received specialized care, there wasn't a significant difference in mortality rates. This is important because it highlights that access to specialty care can greatly improve outcomes for vulnerable patients.
Who this helps: This helps patients with HCM, especially those from lower socioeconomic backgrounds.
Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.
2019
International journal of cardiology. Heart & vasculature
Balakumaran K, Patil A, Marsh S, Ingrassia J, Kuo CL +3 more
Plain English This study looked at how a specialized clinic for heart failure could improve treatment for patients with reduced heart function. It found that after joining the clinic, patients increased their use of recommended heart medications, rising from an average of 0.54 to 1.52 medications at target doses. Additionally, patients showed significant improvement in heart function, with their heart's pumping ability increasing from 21.8% to 36.2%, and there was a decrease in hospital visits due to heart failure.
Who this helps: This benefits patients with heart failure and their doctors by providing better treatment options and improving health outcomes.
Measured Physical Activity and 30-Day Rehospitalization in Heart Failure Patients.
2017
Journal of cardiopulmonary rehabilitation and prevention
Waring T, Gross K, Soucier R, ZuWallack R
Plain English This study looked at how physical activity levels after hospital discharge affect the chance of heart failure patients being readmitted within 30 days. Out of 50 patients, 13 (or 26%) were readmitted, and those who were less active were five times more likely to return to the hospital. This is important because encouraging patients to be more active might help prevent these costly and dangerous readmissions.
Who this helps: This helps heart failure patients by highlighting the importance of staying active after leaving the hospital.
Bicuspid aortic valve masquerading as unicuspid aortic valve: A case of markedly compensated congestive heart failure in a young patient.
2006
Connecticut medicine
Borer S, Soucier R
Plain English The researchers studied a young patient with a bicuspid aortic valve, which is a heart condition that can lead to heart failure. Despite the patient having severe heart issues, they only showed mild symptoms, making it hard to diagnose the problem accurately. This matters because understanding such cases can help doctors identify heart conditions earlier, improving treatment and outcomes for patients.
Who this helps: Patients with heart valve issues and their doctors.
Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy.
2004
The American journal of cardiology
Abiose AK, Mansoor GA, Barry M, Soucier R, Nair CK +1 more
Plain English This study looked at how spironolactone, a medication, affects blood vessel function in patients with severe heart failure who are already receiving standard treatments. The researchers found that after 4 weeks of treatment, blood vessel function improved, and this improvement continued at 8 weeks, suggesting that spironolactone helps blood vessels work better by countering negative effects of a hormone called aldosterone. This matters because better blood vessel function can improve heart health and overall outcomes for these patients.
Who this helps: This helps patients with advanced heart failure.
Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study).
2003
Medical science monitor : international medical journal of experimental and clinical research
Soucier R, Silverman D, Abordo M, Jaagosild P, Abiose A +5 more
Plain English This research studied the effects of two medications, propafenone and ibutilide, on patients who developed a type of irregular heartbeat called atrial fibrillation after heart surgery. Out of 42 patients, those treated with ibutilide had a shorter duration of atrial fibrillation, but 90% of them still had the problem return, and overall, neither medication made a difference in how long patients stayed in the hospital or their heart rhythm when they were discharged. This matters because it shows that after heart surgery, atrial fibrillation is often temporary, suggesting that most patients may not need aggressive treatment with these drugs.
Who this helps: This helps patients recovering from heart surgery.
Lavanya Bellumkonda Veena S Rao Juan B Ivey-Miranda Zachary L Cox Ralph Riello Matthew Griffin James Fleming Prasama Sangkachand Margaret O'Brien Francine LoRusso
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.